相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The study of interactions between genome and exposome in the development of systemic lupus erythematosus
Henrik Christian Bidstrup Leffers et al.
AUTOIMMUNITY REVIEWS (2019)
Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies
Sarah Irmscher et al.
NATURE COMMUNICATIONS (2019)
C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3-and C5-Convertases
Fei Zhao et al.
FRONTIERS IN IMMUNOLOGY (2019)
The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis
Maria A. C. Wester Trejo et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
10 most important contemporary challenges in the management of SLE
Renaud Felten et al.
LUPUS SCIENCE & MEDICINE (2019)
Autoantibodies Against C3b-Functional Consequences and Disease Relevance
Vasil V. Vasilev et al.
FRONTIERS IN IMMUNOLOGY (2019)
Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy
Perrine Jullien et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Vasculitis update: pathogenesis and biomarkers
Paul Brogan et al.
PEDIATRIC NEPHROLOGY (2018)
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
Moglie Le Quintrec et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
IgA nephropathy: new insights into the role of complement
Jurgen Floege et al.
KIDNEY INTERNATIONAL (2018)
Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy
Li Zhu et al.
KIDNEY INTERNATIONAL (2018)
Complete functional characterization of disease-associated genetic variants in the complement factor H gene
Hector Martin Merinero et al.
KIDNEY INTERNATIONAL (2018)
Genomic medicine for kidney disease
Emily E. Groopman et al.
NATURE REVIEWS NEPHROLOGY (2018)
Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action
Douglas Sheridan et al.
PLOS ONE (2018)
Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling
Chao Hu et al.
JOURNAL OF IMMUNOLOGY (2018)
Factor H Autoantibodies and Membranous Nephropathy
Claudia Seikrit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN
Roberta Donadelli et al.
FRONTIERS IN IMMUNOLOGY (2018)
Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy
Franziska von Haxthausen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Haemolytic uraemic syndrome
Diana Karpman et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2
Sadam Yaseen et al.
FASEB JOURNAL (2017)
Complement Recognition Pathways in Renal Transplantation
Christopher L. Nauser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Complement factor H-related proteins in IgA nephropathy-sometimes a gentle nudge does the trick
Joshua M. Thurman et al.
KIDNEY INTERNATIONAL (2017)
Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy
Nicholas R. Medjeral-Thomas et al.
KIDNEY INTERNATIONAL (2017)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Timothy H. J. Goodship et al.
KIDNEY INTERNATIONAL (2017)
Novel insights into the expression pattern of anaphylatoxin receptors in mice and men
Yves Laumonnier et al.
MOLECULAR IMMUNOLOGY (2017)
Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice
Juan S. Danobeitia et al.
PLOS ONE (2017)
Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4
HongBin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Translational Aspects of Primary Membranous Nephropathy
Elion Hoxha et al.
SEMINARS IN NEPHROLOGY (2017)
Kidney Diseases Associated With Alternative Complement Pathway Dysregulation and Potential Treatment Options
Prateek Sanghera et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Novel mechanisms and functions of complement
George Hajishengallis et al.
NATURE IMMUNOLOGY (2017)
Primary Membranous Nephropathy
William G. Couser
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Functional and structural insight into properdin control of complement alternative pathway amplification
Dennis V. Pedersen et al.
EMBO JOURNAL (2017)
IgA Nephropathy
Jennifer C. Rodrigues et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy
Nicola M. Tomas et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
IgA nephropathy and infections
Cristiana Rollino et al.
JOURNAL OF NEPHROLOGY (2016)
Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy
Ya-Ling Zhai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese
Jingyuan Xie et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Immunosuppressant-induced reduction of proteinuria in IgAN
Juergen Floege et al.
NATURE REVIEWS NEPHROLOGY (2016)
Anti-complement-factor H-associated glomerulopathies
Marie-Agnes Dragon Durey et al.
NATURE REVIEWS NEPHROLOGY (2016)
Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways
Andrew S. Bomback et al.
KIDNEY INTERNATIONAL REPORTS (2016)
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth
Liam G. Coulthard et al.
JOURNAL OF IMMUNOLOGY (2015)
The role of complement in C3 glomerulopathy
Peter F. Zipfel et al.
MOLECULAR IMMUNOLOGY (2015)
Atypical aHUS: State of the art
Carla M. Nester et al.
MOLECULAR IMMUNOLOGY (2015)
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Markus Goedel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy
Li Zhu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Complement and Its Receptors: New Insights into Human Disease
V. Michael Holers
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy
Elion Hoxha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Nicola M. Tomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genetic Variants in C5 and Poor Response to Eculizumab
Jun-ichi Nishimura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
Peter Hillmen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
C3 glomerulopathy: consensus report
Matthew C. Pickering et al.
KIDNEY INTERNATIONAL (2013)
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome
Mathieu Lemaire et al.
NATURE GENETICS (2013)
The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome
Agnes Szilagyi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
Lucy V. Holmes et al.
PLOS ONE (2013)
The Role of the Complement System in Acute Kidney Injury
James W. McCullough et al.
SEMINARS IN NEPHROLOGY (2013)
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Andrew S. Bomback et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Marina Noris et al.
NATURE REVIEWS NEPHROLOGY (2012)
Membranoproliferative Glomerulonephritis - A New Look at an Old Entity
Sanjeev Sethi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eculizumab and Refractory Membranoproliferative Glomerulonephritis
Seetha Radhakrishnan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G. Gharavi et al.
NATURE GENETICS (2011)
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility
Jian Zhao et al.
PLOS GENETICS (2011)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Complement regulators and inhibitory proteins
Peter F. Zipfel et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The C-terminus of complement factor H is essential for host cell protection
Mihaly Jozsi et al.
MOLECULAR IMMUNOLOGY (2007)
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
Peter F. Zipfel et al.
PLOS GENETICS (2007)
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)
M. A. Abrera-Abeleda et al.
JOURNAL OF MEDICAL GENETICS (2006)